Navigation Links
Gerresheimer Expands in the Global Pharmaceutical Plastic Business
Date:9/22/2009

DUSSELDORF, Germany, September 22 /PRNewswire-FirstCall/ -- The Gerresheimer Group expands its activities in the pharmaceutical plastic business with two strategically significant investments in the USA and Europe. This week the company is almost simultaneously opening a new research and development center for medical plastic systems in the USA as well as a new production center for pharmaceutical plastic packaging in Spain. "Plastics are increasingly gaining in importance within our highly specialized service portfolio for the international pharmaceutical industry," Gerresheimer AG CEO Dr. Axel Herberg says. "The pharmaceutical plastic business has meanwhile become the division with the highest growth rate, which we are continu-ing to expand systematically. These are crucial investments in the Gerresheimer Group's growth."

The new technological center in Peachtree City (Georgia/USA) is opening up a new dimension for the Group's flourishing business with American industrial clients from the pharmaceutical, diagnostics and medical technology industry. As a full service provider for medical plastic systems, Gerresheimer has upgraded the US location, which has until recently been limited to manufacturing, to become a comprehensively operating research, development and production center. In the American market the Group now has facilities at the front end of its customized serial production of entire product and process development comparable to those only available in Europe up to now. The product range in this field includes highly developed inhalation systems for the treatment of respiratory diseases as well as insulin pen systems, skin-prick aids and lancets for the diabetes sector, which is also growing steadily.

The newly opened plant in Masalaves in Spain (region of Valencia) is also highly significant with regard to the broad market of standardized pharmaceutical system packaging made of plastics. The plant is deemed to be the biggest production center of its kind in Southern Europe and is a significant strategic base for Gerresheimer there as well as in the Central European region. Pharmaceutical bottles and multifunctional dosage and closure systems, for example for eye drops, contact lens care products, nose sprays as well as tablets, are being produced there.

With the help of significant acquisitions, targeted investments and organic growth Gerresheimer has accelerated its plastics business during the past five years and developed it into an internationally leading market force. All in all, the company now possesses 15 locations in Europe, America and Asia in this sector. Both segments of the plastics division are continuing to attain above average growth rates. Accounting for a third of group sales, plastics have already become the largest growth area within the Gerresheimer Group.

About Gerresheimer

Gerresheimer employs around 10,000 people in 40 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totaled EUR1.06bn. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.

    Contact Press:
    Burkhard Lingenberg
    Director Corporate Communication & Marketing
    Phone +49-211-6181-250
    Fax   +49-211-6181-241
    e-mail b.lingenberg@gerresheimer.co

    Contact Investor Relations:
    Anke Linnartz
    Director Corporate Investor Relations
    Phone +49-211-6181-314
    Fax   +49-211-6181-121
    e-mail a.linnartz@gerresheimer.com


'/>"/>
SOURCE Gerresheimer AG
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Standard & Poors Confirms Rating for Gerresheimer
2. Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed
3. Gerresheimer Continues Expansion Course
4. Blackstone Sells Gerresheimer Stake
5. Standard & Poors Raises Gerresheimer Rating to BB+
6. Gerresheimer Starts the Year Successfully in 2008
7. Gerhard Schulze New Chairman of the Supervisory Board of Gerresheimer AG
8. Gerresheimer Finalises Purchase of Spanish Company EDP
9. Gerresheimer Expands its Pharmaceutical Plastic Operations Into Southern Europe and South America
10. Linnartz New Head of Investor Relations of Gerresheimer
11. Growth Trend for Gerresheimer Continues Unabated - Debt Reduction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2016)... (PRWEB) , ... May 01, 2016 , ... Outdoor Growing ... medical marijuana industry, has put the law in the hands of the local ... January 1, 2016, California voted to allow counties to vote on growing regulations by ...
(Date:4/30/2016)... Marne, Michigan (PRWEB) , ... May 01, 2016 , ... ... holistic approach to rehabilitation, has produced a new video that focuses on one of ... of their recent sessions and clips from interviews with a participating patients and the ...
(Date:4/30/2016)... ... April 30, 2016 , ... Powerful tools of ... Mary O'Maley. What is hypnosis and hypnotherapy and why after centuries, it ... pain relief (chronic and acute), birthing processes and medical procedures, depression, anxiety, fear ...
(Date:4/30/2016)... Austin, Texas (PRWEB) , ... April 30, 2016 ... ... time to celebrate the profession and recognize veterinarians’ global impact on public health. ... choose a theme each year, and this year have selected continuing education with ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... 4th, 2016 questioned the use of the HyProCure sinus tarsi implant. ( ... procedure.” EOTTS-HyProCure is a minimally invasive procedure performed, when indicated, to correct ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 2016 Automation is one of ... to the growing demands for productivity in speed, accuracy, ... systems are already adept of a wide range of ... manual labor. Instrumentation continues to evolve, and is poised ... a few years ago. Originally used mostly by the ...
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)... April 28, 2016  Marking its one year ... and ovarian cancer risk test, Color Genomics ... genes that highly impact the most common hereditary ... the Color Test analyzes hereditary cancer risks for ... uterine cancers. The Color Test is physician ordered ...
Breaking Medicine Technology: